Know options for treatment are available
New systems, digital front desks, and analytics help ODs reinvent practice management plans
EyeCon chair Kelly K. Nichols, OD, PhD, MPH, FAAO, shares some of her favorite moments throughout her career and what inspires her to continue pushing the industry forward.
William Hogue, OD, MS, sat down with Optometry Times to outline what symptoms and risk factors eye care providers should look out for in identifying central serous chorioretinopathy in their patients, as well as what treatment options are available.
Modern technology enables early detection, individualized solutions.
Considerations in the treatment of diabetic retinopathy and diabetic macular edema.
A task force of eye care providers is asking for feedback on newly-developed guidelines for managing diabetic retinopathy in their patients.
Gleb Sukhovolskiy discusses his 2023 AAOpt presentation, "Optometrist’s Guide to MIGS and the Continuing Evolution of Glaucoma Treatment."
Long-term success of contact lens wearers attributed to education, professional input on cleaning methods
Ambient listening and transcription provide promising impact on the patient care experience.
Brad Sutton, OD, FAAO, FORS, discusses key takeaways from his discussion, "Genetic testing in AMD: critical, useful, or inappropriate," which he presented during the 2022 American Academy of Optometry meeting.
Rapid macular thinning often precedes traditional symptoms.
The quality of options for patients has improved in recent years.
Understand the condition’s structural, innervational, neurological, and genetic abnormalities
One OD has polished a 4 step process of introducing new contact lens technology to patients
Research indicates that too much technology usage results in negative effects on eyesight.
Respecting the clinical importance of the pachychoroid spectrum is vital when analyzing OCT scans.
This imaging technique provides depth-resolved images of retinal vasculature.
Potential presbyopia treatment coming
What axial length readings and crystalline lens power tell you.
Ben Bergo, CEO of Visus, shares data from the company's pivotal phase 3 BRIO-1 trial, as well as answers questions about Brimochol PF.
Clinicians must think creatively for solutions to vocational rehabilitation
Marsha Link, PhD, uses three words—Imagine, Prepare, and Optimize—to encourage women to assess their current leadership journey, strategically plan for advancement, and explore new opportunities for growth and impact in vision care.
Michele Andrews, OD, vice president of professional and government affairs for CooperVision, and Terri A. Gossard, OD, MS, member of the AOA board of trustees, sat down with Optometry Times to discuss the goals and tactics of The Myopia Collective.
Graham Erickson, OD, FAAO, FCOVD, gives key takeaways of his presentation, "Sports vision grand rounds," which he presented during the 2023 AOA Optometry's Meeting in Washington, DC.
Imaging can elucidate visual prognosis and disease progression risk.
Increased pressure and inflammation require prompt treatment to avoid complications.